| Revenue | NOK 0 | — |
| EBITDA | NOK -61K | +15% |
| Net profit | NOK -210K | +5% |
| Total assets | NOK 151K | -48% |
| Equity | NOK -941K | -29% |
| Employees | 0 | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −3 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −207 | −404 | −66 | −37 | −23 | −27 | −8 | −73 | −61 |
| Depreciation & amort. | −14 | −41 | −73 | −96 | −115 | −100 | −0 | −147 | −147 |
| EBIT | −221 | −445 | −140 | −133 | −138 | −127 | −8 | −220 | −209 |
| Net financials | 0 | −0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 |
| Profit before tax | −220 | −446 | −140 | −133 | −138 | −127 | −8 | −220 | −210 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −220 | −446 | −140 | −133 | −138 | −127 | −8 | −220 | −210 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 393 | 192 | 398 | 388 | 360 | 313 | 430 | 291 | 151 |
| Equity | 380 | −66 | −205 | −338 | −476 | −603 | −511 | −731 | −941 |
| Long-term debt | 14 | 249 | 595 | 717 | 836 | 910 | 941 | 80 | 150 |
| Short-term debt | 0 | 9 | 9 | 9 | 0 | 6 | 0 | 941 | 941 |
| Total debt | 14 | 258 | 604 | 726 | 836 | 916 | 941 | 1 021 | 1 091 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KA Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Oslo Tannlege As | Company | 34.0% | 34.0% | 2022 |
Medec As | Company | 15.0% | 15.0% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Kevin Andre Hermansen | Chief Executive Officer | 0 companies |
| Dag Audun Andersen | Board of Directors | 0 companies |
| Trond Halvard Ellingsen | Board of Directors | 0 companies |